Literature DB >> 6448684

Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum(II).

E S Kleinerman, L A Zwelling, A V Muchmore.   

Abstract

The effect of the antineoplastic agent cis-diamminedichloroplatinum(II) (cis-DDP) on spontaneous cytotoxicity of human mononuclear cells in vitro was assessed. cis-DDP enhanced spontaneous monocyte-mediated cytotoxicity 300% compared to control values. Further, this spontaneous monocyte killing developed earlier (3 to 4 days) than did that of untreated cells (5 to 7 days). Since monocyte cytotoxicity is under the control of lymphocyte suppressor cells, the effect of cis-DDP on separated populations of lymphocytes and monocytes was examined. Unlike X-irradiation which enhanced monocyte cytotoxicity through the indirect pathway of inactivation of lymphocyte suppressors, cis-DDP directly stimulated the monocyte population. Direct stimulation of killer monocytes may be an important mechanism of the antitumor effect of cis-DDP.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6448684

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Effect of interferon-gamma priming on the activation of murine peritoneal macrophages to tumouricidal state by cisplatin, IL-1, and tumour necrosis factor (TNF): production of IL-1 and TNF.

Authors:  A Sodhi; R K Singh; S M Singh
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 2.  Antitumor activity of platinum complexes.

Authors:  J Drobník
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Normalization of defective monocyte chemotaxis during chemotherapy in patients with small cell anaplastic carcinoma of the lung.

Authors:  H Nielsen; J Bennedsen; P Dombernowsky
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  In vitro tumor cell killing by peritoneal macrophages from mitomycin C-treated rats.

Authors:  T Ogura; H Shindo; O Shinzato; M Namba; T Masuno; T Inoue; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

5.  Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.

Authors:  N Saijo; E Shimizu; N Irimajiri; A Ozaki; K Kimura; T Takizawa; H Niitani
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

6.  Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: interim results of a phase I trial.

Authors:  J T Rubin; M T Lotze; D Rosenfelder; A Brumfield; R Howells; R Schwartz; S Sylvestri; J Sammon; K Bron; P Orens
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

7.  Monocyte chemotaxis in patients with nonseminomatous testicular carcinoma. Effect of chemotherapy.

Authors:  H Nielsen; M Rørth; J Bennedsen
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

8.  Immune response of mice exposed to cis-diamminedichloroplatinum.

Authors:  O Bagasra; L Currao; L R DeSouza; J W Oosterhuis; I Damjanov
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

9.  Effects of low-dose mafosfamid on the lymphokine-activated killer cell activity of peripheral blood mononuclear cells determined by a clonogenic microassay.

Authors:  H R Maurer; C Echarti
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

10.  Effect of cisplatin upon expression of in vivo immune tumor resistance.

Authors:  E D Crum
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.